iBio (IBIO) Operating Leases (2021 - 2026)
iBio (IBIO) posted Operating Leases of $1.65 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 24.9% from $2.2 million a year earlier and down 7.9% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Operating Leases (2021 - 2026) Analysis & Trends
Since fiscal Q1 2022, iBio has reported Operating Leases for 20 quarters.
- Annual Operating Leases has declined for four consecutive fiscal years, with a four-year compound annual growth rate of -17.2% (FY2022 to FY2026).
- In prior fiscal years, iBio's Operating Leases was $2.2 million in FY2025 (-18.2%), $2.69 million in FY2024 (-14.0%), $3.13 million in FY2023 (-11.1%) and $3.51 million in FY2022.
- The fiscal Q4 2026 figure stands as the lowest quarterly Operating Leases in data going back to fiscal Q1 2022.
- On a year-over-year basis, Operating Leases has declined in each of the last 16 quarters, with an average decline of 19.1% over the last eight quarters.
- Over the past five years, the year-over-year decline in Operating Leases ranged from 1.0% (fiscal Q1 2023) to 41.9% (fiscal Q3 2023).
- According to Business Quant data, Operating Leases for the three prior fiscal quarters was $1.79 million (Q3 2026), $1.93 million (Q2 2026) and $2.07 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | iBio | 87.41 Mn | -177.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.65 Mn |
| Mar 31, 2026 | 1.79 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 2.07 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.69 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Dec 31, 2023 | 2.91 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Jun 30, 2023 | 3.13 Mn |
| Mar 31, 2023 | 3.23 Mn |
| Dec 31, 2022 | 3.32 Mn |
| Sep 30, 2022 | 3.42 Mn |
| Jun 30, 2022 | 3.51 Mn |
| Mar 31, 2022 | 5.55 Mn |
| Dec 31, 2021 | 5.40 Mn |
| Sep 30, 2021 | 3.46 Mn |
API Access
iBio Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();